LKB1 protein expression in neuroendocrine tumors of the lung-Reference-Cited by-同舟云学术

LKB1 protein expression in neuroendocrine tumors of the lung

Published:2008-01-10 Issue:2 Volume:58 Page:84-88
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:

Author:

Amin Randa Mahmoud Sobhi,Hiroshima Kenzo,Iyoda Akira,Hoshi Kazuei,Honma Koichi,Kuroki Motoo,Kokubo Takeshi,Fujisawa Takehiko,Miyagi Yohei,Nakatani Yukio

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1827.2007.02194.x/fullpdf

Reference25 articles.

1. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid;Travis;Am J Surg Pathol,1998

2. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology;Iyoda;Cancer,2001

3. LKB1, the multitasking tumour suppressor kinase;Marignani;J Clin Pathol,2005

4. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome;Esteller;Oncogene,2000

5. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung;Sanchez-Cespedes;Cancer Res,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity;Signal Transduction and Targeted Therapy;2024-01-05

2. Opportunities and Challenges of Kava in Lung Cancer Prevention;International Journal of Molecular Sciences;2023-05-31

3. LKB1 phosphorylation and deactivation in lung cancer by NNAL, a metabolite of tobacco-specific carcinogen, in an isomer-dependent manner;Oncogene;2022-07-14

4. NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner;2021-06-15

5. Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection;OncoTargets and Therapy;2018-03